DBD Stock Overview
Manufactures and trades in pharmaceuticals and medical equipment in Vietnam.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for DBD from our risk checks.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫48,750.00 |
| 52 Week High | ₫51,400.00 |
| 52 Week Low | ₫39,000.00 |
| Beta | 0.070 |
| 11 Month Change | 8.82% |
| 3 Month Change | 18.90% |
| 1 Year Change | 3.46% |
| 33 Year Change | 56.56% |
| 5 Year Change | 51.55% |
| Change since IPO | 81.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| DBD | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -2.9% | -0.06% | 0.1% |
| 1Y | 3.5% | 20.7% | 14.7% |
Return vs Industry: DBD underperformed the VN Pharmaceuticals industry which returned 20.7% over the past year.
Return vs Market: DBD underperformed the VN Market which returned 14.7% over the past year.
Price Volatility
| DBD volatility | |
|---|---|
| DBD Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 3.2% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in VN Market | 6.8% |
| 10% least volatile stocks in VN Market | 2.2% |
Stable Share Price: DBD has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: DBD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,335 | Huong Thi Pham | www.bidiphar.com |
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; antifungal and antiviral drugs; hemodialysis solutions; hepatobiliary; analgesic and antipyretic drugs; anti-inflammatory analgesic drugs; drugs for muscle, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs for brain circulation improvement; vitamins and minerals; endocrine hormones; respiratory drugs; antifungal and antiviral drugs; antiallergy drugs; dermatologic drugs; antidote; drugs for treating lipid disorders; and supplements. The company also offers medicine decoction stoves, water distillers, distilled water tanks, hand sanitizer equipment, medical solid waste incinerators, washing machines, autoclave machines, drying cabinets, and distilled water for medical industry.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Fundamentals Summary
| DBD fundamental statistics | |
|---|---|
| Market cap | ₫4.56t |
| Earnings (TTM) | ₫254.65b |
| Revenue (TTM) | ₫1.69t |
17.9x
P/E Ratio2.7x
P/S RatioIs DBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DBD income statement (TTM) | |
|---|---|
| Revenue | ₫1.69t |
| Cost of Revenue | ₫875.78b |
| Gross Profit | ₫818.36b |
| Other Expenses | ₫563.71b |
| Earnings | ₫254.65b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.72k |
| Gross Margin | 48.31% |
| Net Profit Margin | 15.03% |
| Debt/Equity Ratio | 2.9% |
How did DBD perform over the long term?
See historical performance and comparison